@vettaiyan929381@bharathFF4@TVKVijayHQ No da kalla olu support lam illa ana adhu trisha illa nu solren avlo thaโฆ. So adhu ungomma tha๐๐๐๐๐ enna gummunu dress pannirka ๐๐
@vettaiyan929381@bharathFF4@TVKVijayHQ En Aaatha apdi poga maata pathini oru nee mooku verthunu pesradha patha ungotha va irupalo kelu da abortion edhana acha nu๐๐๐๐๐๐๐๐๐๐๐ฆ
#Jailer2 North Indian Distributor announcement loading โค๏ธโ๐ฅโค๏ธโ๐ฅโค๏ธโ๐ฅ๐งจ๐งจ๐งจ๐ฅ๐ฅ๐ฅ๐ค๐ค๐ค๐ฅณ๐ฅณ๐ฅณ
#SuperstarRajinikanth#Thalaivar
$CADL Phase 2a data for aglatimagene besadenovec plus valacyclovir in unresectable NSCLC show a durable survival tail with mOS of 21.5 months in cohort 2, plus 37% of PD-ICI patients alive beyond 24 months and 69% of evaluable patients with >1 lesion exhibiting abscopal reductions. Biomarker signals include higher cytotoxic T cell infiltration and expanded activated CD8+ effector/central memory T cells, with elevated granzymes after the second injection, while safety remains manageable (Grade 3 AEs at 13.7%; no dose-limiting toxicities). Non-squamous NSCLC appears to predict greater benefit, suggesting meaningful clinical momentum for this trial regimen.
#Biotech
@the_little_curl@k3_butcher Enda avan than da main lavadaโฆ adhu poga 10 cr tha fraud nu solran enda 10 cr ku proxy panni enna da pryojanam thaili ๐คฆ๐ผ๐คฃ๐คฃ๐คฃ lavada